The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
A61K 31/439 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 31/46 - 8-Azabicyclo [3.2.1] octaneDerivatives thereof, e.g. atropine, cocaine
A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
42 - Scientific, technological and industrial services, research and design
Goods & Services
Software as a service (SAAS) featuring a computer software platform in the field of insurance for use by health care providers for submitting health insurance claims, tracking status of health insurance claims, verifying patient eligibility and tracking patient utilization of benefits, requesting and verifying insurance authorizations for treatment, and managing and appealing claim denials.
42 - Scientific, technological and industrial services, research and design
Goods & Services
Software as a service (SAAS) featuring a computer software platform in the field of insurance for use by health care providers for submitting health insurance claims, tracking status of health insurance claims, verifying patient eligibility and tracking patient utilization of benefits, requesting and verifying insurance authorizations for treatment, and managing and appealing claim denials.
16.
EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS
The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
A61K 31/46 - 8-Azabicyclo [3.2.1] octaneDerivatives thereof, e.g. atropine, cocaine
A61K 9/00 - Medicinal preparations characterised by special physical form
A61K 31/40 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
A61K 31/5386 - 1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
Some embodiments of the present disclosure present methods and systems for remotely capturing an image of an eye of a user via a user interface bidirectionally linked to a remote server that is configured to anonymize data communicated from the user device. In some embodiments, a user device may activate its camera after receiving a request at the user interface from the remote server. Further, the user interface may determine a zoom level for the camera based on a pre-set zoom level corresponding to the type of the user device, wherein the pre-set zoom level corresponding to the non-portable user device is greater than the pre-set zoom level corresponding to the portable user device; and capture the image based on the determined zoom level. In some instances, the user device may transmit the data including the captured image to the remote server via an encrypted bi-directional communication link.
Collection and compilation of information into computer databases in the field of pharmaceuticals; providing an on-line database providing business intelligence in the field of inventory management, namely, the monitoring, storage, and distribution in the field of pharmaceuticals
Administering a program for patient assistance;
administering a program to assist health care providers and
staff regarding billing and reimbursement; administering a
program for patient assistance for coverage of medications;
administering a program to health care providers to bill for
in-office use of medications.
Administering a program for patient assistance;
administering a program to assist health care providers and
staff regarding billing and reimbursement; administering a
program for patient assistance for coverage of medications;
administering a program to health care providers to bill for
in-office use of medications.
Provided herein are formulations and compositions for ocular diseases or disorders such as dry eye disease. Further provided herein are methods for manufacturing ocular formulations and compositions.
A61F 9/00 - Methods or devices for treatment of the eyesDevices for putting in contact-lensesDevices to correct squintingApparatus to guide the blindProtective devices for the eyes, carried on the body or in the hand
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
A61K 47/24 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
(1) Administering a program for patient assistance; administering a program to assist health care providers and staff regarding billing and reimbursement; administering a program for patient assistance for coverage of medications; administering a program to health care providers to bill for in-office use of medications.
(1) Administering a program for patient assistance; administering a program to assist health care providers and staff regarding billing and reimbursement; administering a program for patient assistance for coverage of medications; administering a program to health care providers to bill for in-office use of medications.
Pharmaceutical compositions for intraocular injection and for topical administration are described, the compositions comprise therapeutically effective quantity of at least two mydriatic compounds, a non-steroid anti-inflammatory drug, and further, optionally, a gel forming compound, an anesthetic, an antibiotic, and a metal chelator. Methods for fabricating the compositions and using them are also described.
A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine
A61K 31/407 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A61K 31/196 - Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 31/4409 - Non-condensed pyridinesHydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
A61K 47/18 - AminesAmidesUreasQuaternary ammonium compoundsAmino acidsOligopeptides having up to five amino acids
A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for ophthalmological use containing natamycin; topical antifungal compositions for ophthalmological use containing natamycin
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for ophthalmological use containing chloroprocaine; topical anesthetic gel for ophthalmological use containing chloroprocaine
Business administration of a program for patient assistance in accessing medical records and billing; business administration of a program to assist health care providers and staff regarding billing and reimbursement; business administration of a program for patient assistance for coverage of medications; business administration of a program to health care providers to bill for in-office use of medications
Business administration of a program for patient assistance in accessing medical records and billing; business administration of a program to assist health care providers and staff regarding billing and reimbursement; business administration of a program for patient assistance for coverage of medications; business administration of a program to health care providers to bill for in-office use of medications
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Medical services, namely, providing a website enabling users
to prescribe pharmaceuticals (term considered too vague by
the International Bureau - Rule 13 (2) (b) of the
Regulations).
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Medical services, namely, providing a website enabling users
to prescribe pharmaceuticals (term considered too vague by
the International Bureau - Rule 13 (2) (b) of the
Regulations).
65.
ANTIBACTERIAL COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of at least one glycopeptide antibiotic, at least one aminoglycoside antibiotic, and at least one amino acid. Methods for fabricating the compositions and using them are also described.
A61K 31/7048 - Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
A61K 31/167 - Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
A61K 31/7036 - Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
A61K 31/198 - Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
66.
EXTENDED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE CONDITIONS
The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
The present disclosure encompasses methods and compositions for extended-release formulations for treating ophthalmic conditions. These formulations comprise a pharmaceutical agent, a cationic polymer, a non-ionic polymer, and a pharmaceutical carrier and are essentially preservative free. The formulations provided herein are particularly useful for sustained and controlled release of drugs and have low side effects.
The present disclosure encompasses methods and compositions for staining ocular structures in ophthalmologic procedures. The compositions generally include a mydriatic compound and a dye. The compositions may additionally include a pain-relieving compound and a second mydriatic compound. Also provided herein is a method of delivering a pharmaceutical composition, which includes administering to an eye of a subject an ophthalmic pharmaceutical composition of the present disclosure.
The present invention relates generally to a method of treating infectious conjunctivitis by administering to an infected eye of a subject a composition comprising povidone-iodine and an excipient that reduces the ocular toxicity of the composition, wherein the composition does not include a steroidal anti-inflammatory drug or a non-steroidal anti-inflammatory drug.
The present invention relates generally to a method of treating infectious conjunctivitis by administering to an infected eye of a subject a composition comprising povidone-iodine and an excipient that reduces the ocular toxicity of the composition, wherein the composition does not include a steroidal anti-inflammatory drug or a non-steroidal anti-inflammatory drug.
The present invention relates generally to a method of treating infectious conjunctivitis by administering to an infected eye of a subject a composition comprising povidone-iodine and an excipient that reduces the ocular toxicity of the composition, wherein the composition does not include a steroidal anti-inflammatory drug or a non-steroidal anti-inflammatory drug.
The present disclosure relates to packaged eyelid scrubs as well as methods for making the packaged eyelid scrubs. The packaged eyelid scrubs include a pharmaceutical composition that includes hypochlorous acid and menthol, and a package that includes an opaque airless spray container filled with the pharmaceutical composition. Methods of cleansing an eyelid using the pharmaceutical compositions are also described herein.
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Medical services, namely, providing a website enabling users to prescribe pharmaceuticals (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical compositions for ophthalmological use;
topical anesthetic drop for ophthalmological use;
pharmaceutical compositions for ocular or intraocular
surgery; topical anesthetic gel used prior to ocular
surgeries. Health care services in the nature of vision care, eye
health, ophthalmology services, optometry services, laser
vision service.
05 - Pharmaceutical, veterinary and sanitary products
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Topical anesthetic drop for ophthalmological use;
pharmaceutical compositions for ocular or intraocular
surgery; topical anesthetic gel used prior to ocular
surgeries. Providing temporary use of an online non-downloadable
software for database management in the field of health care
information and enabling users to input data and information
all for treatment and diagnostic purposes. Internet-based health care information services;
telemedicine services; providing health care information by
telephone and the internet; web-based health assessment
services, namely, a series of health-related questions for
response from the user that result in a report that provides
health-related information in the form of recommended
educational resources and treatment information; health care
services, namely, providing eye health care information that
features data and information all for treatment and
diagnostic purposes via a database; health screening in the
field of ophthalmic services.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical compositions for ophthalmological use;
topical anesthetic drop for ophthalmological use;
pharmaceutical compositions for ocular or intraocular
surgery; topical anesthetic gel used prior to ocular
surgeries. Health care services in the nature of vision care, eye
health, ophthalmology services, optometry services, laser
vision service.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Pharmaceutical compositions for ophthalmological use;
topical anesthetic drop for ophthalmological use;
pharmaceutical compositions for ocular or intraocular
surgery; topical anesthetic gel used prior to ocular
surgeries. Health care services in the nature of vision care, eye
health, ophthalmology services, optometry services, laser
vision service.
A61L 2/00 - Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lensesAccessories therefor
A61K 31/4709 - Non-condensed quinolines containing further heterocyclic rings
A61K 31/573 - Compounds containing cyclopenta[a]hydrophenanthrene ring systemsDerivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
A61K 31/196 - Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
A61K 9/00 - Medicinal preparations characterised by special physical form
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Pharmaceutical compositions for ophthalmological use; topical anesthetic drop for ophthalmological use; pharmaceutical compositions for ocular or intraocular surgery; topical anesthetic gel used prior to ocular surgeries. (1) Health care services in the nature of vision care, eye health, ophthalmology services, optometry services, laser vision service.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Pharmaceutical compositions for ophthalmological use; topical anesthetic drop for ophthalmological use; pharmaceutical compositions for ocular or intraocular surgery; topical anesthetic gel used prior to ocular surgeries. (1) Health care services in the nature of vision care, eye health, ophthalmology services, optometry services, laser vision service.
05 - Pharmaceutical, veterinary and sanitary products
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
(1) Pharmaceutical compositions for ophthalmological use; topical anesthetic drop for ophthalmological use; pharmaceutical compositions for ocular or intraocular surgery; topical anesthetic gel used prior to ocular surgeries. (1) Health care services in the nature of vision care, eye health, ophthalmology services, optometry services, laser vision service.
Some embodiments of the present disclosure present methods and systems for remotely capturing an image of an eye of a user via a user interface bidirectionally linked to a remote server that is configured to anonymize data communicated from the user device. In some embodiments, a user device may activate its camera after receiving a request at the user interface from the remote server. Further, the user interface may determine a zoom level for the camera to capture the image of the eye of the user facing the camera and capture the image based on the determined zoom level. In some instances, the user device may transmit the data including the captured image to the remote server via an encrypted bi-directional communication link.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for ophthalmological use; topical anesthetic drop for ophthalmological use; pharmaceutical compositions for ocular or intraocular surgery; topical anesthetic gel used prior to ocular surgeries
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for ophthalmological use; Topical anesthetic drop for ophthalmological use; Pharmaceutical compositions for ocular or intraocular surgery; Topical anesthetic gel used prior to ocular surgeries
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical compositions for ophthalmological use; Topical anesthetic drop for ophthalmological use; Pharmaceutical compositions for ocular or intraocular surgery; Topical anesthetic gel used prior to ocular surgeries
